Evidence map›Paper›PMID 40771071›Full record

Trial reportJournal of cellular and molecular medicine2025

Ischemia-Reperfusion Injury in Free Flaps: Molecular Mechanisms and Protective Effects of Remote Ischemic Preconditioning.

Marius Drysch, Alexander Fiedler, Tabea Kurbacher, Sonja Verena Schmidt, Felix Reinkemeier, Flemming Puscz, Mustafa Becerikli, Maria Fueth, Pia Weskamp, Marcus Lehnhardt and 2 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of cellular and molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07487220 (Non-invasive Remote Ischemic PreConditioning in Free Flaps for Breast Reconstruction), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07487220 nacompletednot on this map

Non-invasive Remote Ischemic PreConditioning in Free Flaps for Breast Reconstruction

TypeinterventionalSponsorRuhr University of BochumRan2021 to 2023Enrolled49ConditionsIschemia-Reperfusion Injury, Free Flap, Conditioning TherapyArmsRemote ischemic preconditiong
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Marius DryschDepartment of Plastic Surgery, BG University Hospital Bergmannsheil, Ruhr University Bochum, Bochum, Germany.ORCID 0000-0001-8447-2694
Alexander FiedlerDepartment of Plastic Surgery, BG University Hospital Bergmannsheil, Ruhr University Bochum, Bochum, Germany.
Tabea KurbacherDepartment of Gynecology and Obstetrics, St. Elisabeth-Hospital, Ruhr University Bochum, Bochum, Germany.
Sonja Verena SchmidtDepartment of Plastic Surgery, BG University Hospital Bergmannsheil, Ruhr University Bochum, Bochum, Germany.
Felix ReinkemeierDepartment of Plastic Surgery, BG University Hospital Bergmannsheil, Ruhr University Bochum, Bochum, Germany.
Flemming PusczDepartment of Plastic Surgery, BG University Hospital Bergmannsheil, Ruhr University Bochum, Bochum, Germany.
Mustafa BecerikliDepartment of Plastic Surgery, BG University Hospital Bergmannsheil, Ruhr University Bochum, Bochum, Germany.ORCID 0000-0002-2695-5273
Maria FuethDepartment of Plastic Surgery, BG University Hospital Bergmannsheil, Ruhr University Bochum, Bochum, Germany.
Pia WeskampDepartment of Plastic Surgery, BG University Hospital Bergmannsheil, Ruhr University Bochum, Bochum, Germany.
Marcus LehnhardtDepartment of Plastic Surgery, BG University Hospital Bergmannsheil, Ruhr University Bochum, Bochum, Germany.
Christoph WallnerDepartment of Plastic Surgery, BG University Hospital Bergmannsheil, Ruhr University Bochum, Bochum, Germany.
Alexander SogorskiDepartment of Plastic Surgery, BG University Hospital Bergmannsheil, Ruhr University Bochum, Bochum, Germany.

Funding

Ruhr-University Bochum
6 · The paper itself

Abstract

Ischemia-reperfusion injury remains a major challenge in free flap surgery, contributing to oxidative stress, inflammation, and cell death that impair tissue viability and outcomes. Remote ischemic preconditioning (RIPC) has emerged as a potential protective strategy by modulating cellular stress responses, but its molecular mechanisms in free flaps remain incompletely understood. We prospectively enrolled 36 female patients undergoing autologous breast reconstruction with mainly deep inferior epigastric perforator (DIEP) free flaps, randomised into three groups: No RIPC, Early RIPC (24 h preconditioning), and Late RIPC (1 h preconditioning). Tissue samples were collected pre-ischemia and post-reperfusion for immunohistochemical and multiplex protein analyses. RIPC did not reduce oxidative stress markers, as 4-hydroxynonenal (4-HNE) levels were comparable across groups, while 3-nitrotyrosine levels paradoxically increased after RIPC. Early RIPC selectively modulated cell death pathways, with decreased expression of mitochondrial apoptotic marker caspase 9 and reduced necroptotic activation of mixed lineage kinase domain-like protein (MLKL) after reperfusion. Caspase 8 showed a transient modulation, suggesting effects on apoptosis-necroptosis crosstalk. Cyclophilin A levels were elevated after reperfusion in RIPC groups, indicating an adaptive stress response. These findings suggest that early RIPC exerts selective protection by modulating apoptosis and necroptosis, rather than broadly reducing oxidative stress. RIPC may represent a targeted strategy to improve free flap survival in reconstructive surgery.

Indexed as

Free Tissue FlapsIschemic PreconditioningReperfusion InjuryAdultAldehydesApoptosisFemaleHumansMammaplastyMiddle AgedOxidative Stress4-hydroxy-2-nonenalAldehydesapoptosisbreast reconstructionfree flap surgeryischemia–reperfusion injurynecroptosisoxidative stressremote ischemic preconditioning

Identifiers

PMID40771071
PMCPMC12329344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.